A Gprc5a Tumor Suppressor Loss of Expression Signature Is Conserved, Prevalent, and Associated with Survival in Human Lung Adenocarcinomas
Increasing the understanding of the impact of changes in oncogenes and tumor suppressor genes is essential for improving the management of lung cancer. Recently, we identified a new mouse lung-specific tumor suppressor—the G protein-coupled receptor 5A (Gprc5a). Microarray analysis of the transcript...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2010-06-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558610800077 |
_version_ | 1811313741981024256 |
---|---|
author | Humam Kadara Junya Fujimoto Taoyan Men Xiaofeng Ye Dafna Lotan Ju-Seog Lee Reuben Lotan |
author_facet | Humam Kadara Junya Fujimoto Taoyan Men Xiaofeng Ye Dafna Lotan Ju-Seog Lee Reuben Lotan |
author_sort | Humam Kadara |
collection | DOAJ |
description | Increasing the understanding of the impact of changes in oncogenes and tumor suppressor genes is essential for improving the management of lung cancer. Recently, we identified a new mouse lung-specific tumor suppressor—the G protein-coupled receptor 5A (Gprc5a). Microarray analysis of the transcriptomes of lung epithelial cells cultured from normal tracheas of Gprc5a knockout and wild-type mice defined a loss-of-Gprc5a gene signature, which revealed many aberrations in cancer-associated pathways. To assess the relevance of this mouse tumor suppressor to human lung cancer, the loss-of-Gprc5a signature was cross species compared with and integrated with publicly available gene expression data of human normal lung tissue and non-small cell lung cancers. The loss-of-Gprc5a signature was prevalent in human lung adenocarcinomas compared with squamous cell carcinomas or normal lung. Furthermore, it identified subsets of lung adenocarcinomas with poor outcome. These results demonstrate that gene expression patterns of Gprc5a loss in nontumorigenic mouse lung epithelial cells are evolutionarily conserved and important in human lung adenocarcinomas. |
first_indexed | 2024-04-13T11:00:05Z |
format | Article |
id | doaj.art-99273ca0dd25466f91b9b4f23c6df843 |
institution | Directory Open Access Journal |
issn | 1476-5586 1522-8002 |
language | English |
last_indexed | 2024-04-13T11:00:05Z |
publishDate | 2010-06-01 |
publisher | Elsevier |
record_format | Article |
series | Neoplasia: An International Journal for Oncology Research |
spelling | doaj.art-99273ca0dd25466f91b9b4f23c6df8432022-12-22T02:49:26ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55861522-80022010-06-0112649950510.1593/neo.10390A Gprc5a Tumor Suppressor Loss of Expression Signature Is Conserved, Prevalent, and Associated with Survival in Human Lung AdenocarcinomasHumam Kadara0Junya Fujimoto1Taoyan Men2Xiaofeng Ye3Dafna Lotan4Ju-Seog Lee5Reuben Lotan6Department of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USADepartment of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USADepartment of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USADepartment of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USADepartment of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USADepartment of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USADepartment of Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USAIncreasing the understanding of the impact of changes in oncogenes and tumor suppressor genes is essential for improving the management of lung cancer. Recently, we identified a new mouse lung-specific tumor suppressor—the G protein-coupled receptor 5A (Gprc5a). Microarray analysis of the transcriptomes of lung epithelial cells cultured from normal tracheas of Gprc5a knockout and wild-type mice defined a loss-of-Gprc5a gene signature, which revealed many aberrations in cancer-associated pathways. To assess the relevance of this mouse tumor suppressor to human lung cancer, the loss-of-Gprc5a signature was cross species compared with and integrated with publicly available gene expression data of human normal lung tissue and non-small cell lung cancers. The loss-of-Gprc5a signature was prevalent in human lung adenocarcinomas compared with squamous cell carcinomas or normal lung. Furthermore, it identified subsets of lung adenocarcinomas with poor outcome. These results demonstrate that gene expression patterns of Gprc5a loss in nontumorigenic mouse lung epithelial cells are evolutionarily conserved and important in human lung adenocarcinomas.http://www.sciencedirect.com/science/article/pii/S1476558610800077 |
spellingShingle | Humam Kadara Junya Fujimoto Taoyan Men Xiaofeng Ye Dafna Lotan Ju-Seog Lee Reuben Lotan A Gprc5a Tumor Suppressor Loss of Expression Signature Is Conserved, Prevalent, and Associated with Survival in Human Lung Adenocarcinomas Neoplasia: An International Journal for Oncology Research |
title | A Gprc5a Tumor Suppressor Loss of Expression Signature Is Conserved, Prevalent, and Associated with Survival in Human Lung Adenocarcinomas |
title_full | A Gprc5a Tumor Suppressor Loss of Expression Signature Is Conserved, Prevalent, and Associated with Survival in Human Lung Adenocarcinomas |
title_fullStr | A Gprc5a Tumor Suppressor Loss of Expression Signature Is Conserved, Prevalent, and Associated with Survival in Human Lung Adenocarcinomas |
title_full_unstemmed | A Gprc5a Tumor Suppressor Loss of Expression Signature Is Conserved, Prevalent, and Associated with Survival in Human Lung Adenocarcinomas |
title_short | A Gprc5a Tumor Suppressor Loss of Expression Signature Is Conserved, Prevalent, and Associated with Survival in Human Lung Adenocarcinomas |
title_sort | gprc5a tumor suppressor loss of expression signature is conserved prevalent and associated with survival in human lung adenocarcinomas |
url | http://www.sciencedirect.com/science/article/pii/S1476558610800077 |
work_keys_str_mv | AT humamkadara agprc5atumorsuppressorlossofexpressionsignatureisconservedprevalentandassociatedwithsurvivalinhumanlungadenocarcinomas AT junyafujimoto agprc5atumorsuppressorlossofexpressionsignatureisconservedprevalentandassociatedwithsurvivalinhumanlungadenocarcinomas AT taoyanmen agprc5atumorsuppressorlossofexpressionsignatureisconservedprevalentandassociatedwithsurvivalinhumanlungadenocarcinomas AT xiaofengye agprc5atumorsuppressorlossofexpressionsignatureisconservedprevalentandassociatedwithsurvivalinhumanlungadenocarcinomas AT dafnalotan agprc5atumorsuppressorlossofexpressionsignatureisconservedprevalentandassociatedwithsurvivalinhumanlungadenocarcinomas AT juseoglee agprc5atumorsuppressorlossofexpressionsignatureisconservedprevalentandassociatedwithsurvivalinhumanlungadenocarcinomas AT reubenlotan agprc5atumorsuppressorlossofexpressionsignatureisconservedprevalentandassociatedwithsurvivalinhumanlungadenocarcinomas AT humamkadara gprc5atumorsuppressorlossofexpressionsignatureisconservedprevalentandassociatedwithsurvivalinhumanlungadenocarcinomas AT junyafujimoto gprc5atumorsuppressorlossofexpressionsignatureisconservedprevalentandassociatedwithsurvivalinhumanlungadenocarcinomas AT taoyanmen gprc5atumorsuppressorlossofexpressionsignatureisconservedprevalentandassociatedwithsurvivalinhumanlungadenocarcinomas AT xiaofengye gprc5atumorsuppressorlossofexpressionsignatureisconservedprevalentandassociatedwithsurvivalinhumanlungadenocarcinomas AT dafnalotan gprc5atumorsuppressorlossofexpressionsignatureisconservedprevalentandassociatedwithsurvivalinhumanlungadenocarcinomas AT juseoglee gprc5atumorsuppressorlossofexpressionsignatureisconservedprevalentandassociatedwithsurvivalinhumanlungadenocarcinomas AT reubenlotan gprc5atumorsuppressorlossofexpressionsignatureisconservedprevalentandassociatedwithsurvivalinhumanlungadenocarcinomas |